Labshake search
Citations for Millipore Sigma :
1 - 32 of 32 citations for p38 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... P38 inhibitor SB202190 (Sigma-Aldrich), gastrin I (Sigma-Aldrich) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... p38 inhibitor SB203580 (Sigma, S8307), p38 inhibitor SB202190 (Sigma ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... p38 inhibitor SB202190 (Sigma, S7076), Gentamycin ...
-
bioRxiv - Cancer Biology 2022Quote: ... P38 inhibitor SB202190 (Sigma-Aldrich), gastrin I (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... p38 inhibitor SB202190 (10µM, Sigma), Rho-kinase/ROCK inhibitor Y-27632 (10µM ...
-
bioRxiv - Cell Biology 2019Quote: ... 10 μM p38 MAPK inhibitor (Sigma), 600 nM TGFβ receptor inhibitor A83-01 ...
-
bioRxiv - Bioengineering 2019Quote: ... P38 inhibitor SB202190 10μM(Sigma-Aldrich), Gastrin I 10nM (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2024Quote: ... p38 inhibitor SB202190 (10 µM, Sigma), Rho-kinase/ROCK inhibitor Y-27632 (10 µM ...
-
bioRxiv - Cancer Biology 2022Quote: ... p38-inhibitors SB202190 [10 μM] (Sigma-Aldrich) and SB203580 [10 μM] (Selleckchem) ...
-
bioRxiv - Immunology 2019Quote: ... p38 MAPK (SB239063, Sigma-Aldrich, 20 μM), and phagocytosis (cytochalasin-D ...
-
bioRxiv - Cell Biology 2021Quote: ... p38 MAP kinase inhibitor (SB202190, Sigma-Aldrich), and Prostaglandin E2 (PGE2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 10 µM P38 inhibitor SB202190 (Sigma-Aldrich), 50% Wnt3a-CM (homemade ...
-
bioRxiv - Neuroscience 2023Quote: ... and p38 inhibitor SB203580 were from Sigma Chemical Co ...
-
bioRxiv - Cancer Biology 2020Quote: ... p38 MAP Kinase Inhibitor (Sigma Aldrich, Arklow, Ireland), U0126 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 3 µM p38 inhibitor SB202190 (Sigma-Aldrich #S7067), and 100 µg/mL Primocin (Invivogen #ant-pm-1) ...
-
bioRxiv - Microbiology 2021Quote: ... p38 MAP Kinase Inhibitor BIRB 796 (MERCK Millipore) was used at 10 μM ...
-
bioRxiv - Genetics 2020Quote: ... 10μM p38 inhibitor SB202190 (supplied by Sigma-Aldrich). This medium was supplemented with the following growth factors ...
-
bioRxiv - Immunology 2020Quote: ... SB (p38/ERK MAP Kinase Inhibitor, Sigma-Aldrich), and NOD1/2 inhibitor GEF (Gefitinib ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3 μM p38 inhibitor SB202190 (Sigma, Cat# 7067). All lung NET organoids and some LCNEC organoids were grown in media additionally supplemented with 0.05 μg/ml EGF (Peprotech ...
-
bioRxiv - Cell Biology 2019Quote: ... The p38 inhibitor SB-203580 was obtained from Sigma. Amphiregulin was ordered from Peprotech.
-
bioRxiv - Biochemistry 2023Quote: ... and 10 µM SB202190 P38 MAPK inhibitor (Sigma-Aldrich). Organoids were maintained in Cultrex BME (R&D systems ...
-
bioRxiv - Microbiology 2021Quote: ... The p38 inhibitor SB203580 ([vehicle solution DMSO], 10 μM, Sigma) was added 2 h before infection ...
-
bioRxiv - Cancer Biology 2020Quote: ... and rabbit polyclonal anti-p38 antibody (Sigma, St. Louis, MO) which was used as a loading control ...
-
bioRxiv - Cancer Biology 2022Quote: ... a p38 inhibitor and 0.1 µM wortmannin (Sigma-Aldrich, W1628), a PI3K inhibitor ...
-
bioRxiv - Developmental Biology 2021Quote: ... p38 MAPK signalling was inhibited by 25μM SB 203580 (Sigma-Aldrich). Nitric oxide synthase (NOS ...
-
bioRxiv - Genetics 2020Quote: ... PGE2 is excluded and 30μM of P38 inhibitor SB202190 (Sigma-Aldrich) is added to expansion medium for cystic fibrosis organoids ...
-
bioRxiv - Neuroscience 2022Quote: ... SB 203580 was used to block p38 MAPK activity (Sigma, #559389). For drug treatment ...
-
bioRxiv - Cancer Biology 2023Quote: ... a highly specific p38 MAPK inhibitor (10 µM; EMD Millipore, Billerica, MA); and ERK activation inhibitor peptide 1 ...
-
bioRxiv - Cell Biology 2023Quote: ... The p38-MAPK signaling pathway was inhibited using 50 µM SB203580 (Sigma Aldrich, dissolved in DMSO). After pre-treatment with either inhibitor for 1 h ...
-
bioRxiv - Molecular Biology 2022Quote: ... The p38 MAPK inhibitor SB203580 (#S8307) and ERK inhibitor U0126 (#U120) were purchased from Sigma-Aldrich (St Louis, MO). They were added (20 μM ...
-
bioRxiv - Cancer Biology 2019Quote: ... the p38 inhibitor SB202190 (1073) was obtained from SYNkinase (3052, Australia) and the mTOR inhibitor Rapamycin (553210) was obtained from Sigma-Aldrich.
-
bioRxiv - Cancer Biology 2020Quote: ... p38 inhibitor SB203580 and MLK inhibitor URMC-099 were further diluted to the desired concentration with 50 %PEG-400 (Sigma, 91893) + 50 %saline ...